AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1

AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1

No trades
See on Supercharts

Key facts today


Morningstar's analysis indicates that U.S. tariffs and drug pricing reforms will have a limited impact on AbbVie, posing low immediate risk to prescription drug access.
Analyze the impactAnalyze the impact
Market capitalization
‪371.72 B‬USD
1.80USD
‪3.76 B‬USD
‪50.04 B‬USD
Beta (1Y)
0.03

About AbbVie Inc.


CEO
Robert A. Michael
Website
Headquarters
North Chicago
Founded
2011
ISIN
ARBCOM4603M9
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Check out other big names from the same industry as ABBVD.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
ABBV4693581
AbbVie Inc. 4.25% 14-NOV-2028
Yield to maturity
Maturity date
Nov 14, 2028
ABBV5758813
AbbVie Inc. 4.8% 15-MAR-2027
Yield to maturity
Maturity date
Mar 15, 2027
ABBV5759196
AbbVie Inc. 5.5% 15-MAR-2064
Yield to maturity
Maturity date
Mar 15, 2064
ABBV5759195
AbbVie Inc. 5.4% 15-MAR-2054
Yield to maturity
Maturity date
Mar 15, 2054
ABBV5084339
AbbVie Inc. 2.95% 21-NOV-2026
Yield to maturity
Maturity date
Nov 21, 2026
ABBV4693583
AbbVie Inc. 4.875% 14-NOV-2048
Yield to maturity
Maturity date
Nov 14, 2048
ABBV5082874
AbbVie Inc. 4.55% 15-MAR-2035
Yield to maturity
Maturity date
Mar 15, 2035
ABBV5006799
AbbVie Inc. 4.85% 15-JUN-2044
Yield to maturity
Maturity date
Jun 15, 2044
ABBV4036937
AbbVie Inc. 4.4% 06-NOV-2042
Yield to maturity
Maturity date
Nov 6, 2042
ABBV5759204
AbbVie Inc. 5.35% 15-MAR-2044
Yield to maturity
Maturity date
Mar 15, 2044
ABBV5084327
AbbVie Inc. 3.2% 21-NOV-2029
Yield to maturity
Maturity date
Nov 21, 2029

See all ABBVD bonds